None listed
Conditions
Interventions
Intervention1: Anti Acne Gel: The product is applied on whole face once in a day for the period of 7 days.
Control Intervention1: Nil: NA
Sponsors
Alvio Pharmaceuticals Pvt Ltd / UNCAP
Eligibility
Inclusion criteria
Inclusion criteria: 1)Indian female subjects 2)Healthy subjects 3)Skin is healthy on the studied anatomic unit 4)Having mild to moderate acne. 5)Having oily to mixed oily skin type
Exclusion criteria
Exclusion criteria: 1)Being pregnant or breastfeeding or having stopped breastfeeding in the past three months. 2)Having refused to give her assent by not signing the consent form. 3)Taking part in another study liable to interfere with this study. 4)Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months). 5)Having a progressive asthma (either under treatment or last fit in the last 2 years) 6)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months). 8)Being epileptic. 9)Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 10)Having cutaneous hypersensitivity. 11)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 12)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 13)Having changed her/his cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit. 14)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted) 15)Having applied hair oil during the entire duration of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety on skin and reduction in acneTimepoint: Baseline, Day 1, Day 2 and Day 7 | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Mohit Lalvani
MASCOT-SPINCONTROL India Pvt. Ltd.
Outcome results
None listed